-
EP2522339
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2522339
| EP2522339 - Amorphous drug transdermal systems, manufacturing methods, and stabilization [Right-click to bookmark this link] | Status | The application has been refused Status updated on 10.06.2018 Database last updated on 02.08.2024 | |
| Former | Examination is in progress Status updated on 09.12.2016 | Most recent event Tooltip | 28.09.2018 | Refusal of application | published on 31.10.2018 [2018/44] | Applicant(s) | For all designated states MYLAN TECHNOLOGIES, INC. 110 Lake Street St. Albans, VT 05478 / US | [2012/46] | Inventor(s) | 01 /
Tang, Jiansheng 115 Franklin Tpke, Ste 13 Mahwah New Jersey 07430-1363 / US | 02 /
Deverich, Joseph, M. 25 Joseph Lane Essex Junction, VT 05452 / US | 03 /
Miller, Kenneth, J., II. 17 Quarry Court St. Albans, VT 05478 / US | 04 /
Beste, Russell, D. 43 Stonington Circle So. Burlington, VT Vermont 05403 / US | [2012/46] | Representative(s) | Cooke, Richard Spencer Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB | [N/P] |
| Former [2012/46] | Eddowes, Simon Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB | Application number, filing date | 12179591.8 | 11.03.2008 | [2012/46] | Priority number, date | US20070725159 | 16.03.2007 Original published format: US 725159 | [2012/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2522339 | Date: | 14.11.2012 | Language: | EN | [2012/46] | Type: | A3 Search report | No.: | EP2522339 | Date: | 22.01.2014 | Language: | EN | [2014/04] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 07.01.2014 | Classification | IPC: | A61K9/70 | [2012/46] | CPC: |
A61K9/7053 (EP,US);
A61K9/70 (KR);
A61K9/7038 (CN);
A61K31/56 (KR);
A61K47/34 (KR);
A61K9/7069 (EP,US);
A61P13/02 (EP);
A61P13/10 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
A61P5/24 (EP);
A61P5/26 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2012/46] | Extension states | AL | Not yet paid | BA | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | Transdermale Systeme für amorphe Arzneimittel, Herstellungsverfahren und Stabilisierung | [2012/46] | English: | Amorphous drug transdermal systems, manufacturing methods, and stabilization | [2012/46] | French: | Systèmes transdermiques pour médicament amorphe, procédés de fabrication et stabilisation | [2012/46] | Examination procedure | 17.07.2014 | Amendment by applicant (claims and/or description) | 17.07.2014 | Examination requested [2014/35] | 08.12.2016 | Despatch of a communication from the examining division (Time limit: M06) | 19.06.2017 | Reply to a communication from the examining division | 01.06.2018 | Application refused, date of legal effect [2018/44] | 01.06.2018 | Date of oral proceedings | 11.06.2018 | Despatch of communication that the application is refused, reason: substantive examination [2018/44] | 11.06.2018 | Minutes of oral proceedings despatched | Parent application(s) Tooltip | EP08726714.2 / EP2136795 | Divisional application(s) | EP14192914.1 / EP2848248 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20080726714) is 28.07.2010 | Fees paid | Renewal fee | 07.08.2012 | Renewal fee patent year 03 | 07.08.2012 | Renewal fee patent year 04 | 07.08.2012 | Renewal fee patent year 05 | 08.03.2013 | Renewal fee patent year 06 | 10.03.2014 | Renewal fee patent year 07 | 06.03.2015 | Renewal fee patent year 08 | 31.03.2016 | Renewal fee patent year 09 | 27.03.2017 | Renewal fee patent year 10 | 23.03.2018 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US2005124743 (NIERLE JENS [DE], et al) [X] 1,9,10,16,17 * paragraphs [0002] , [0011] , [0016] , [0043] , [0050] , [0051] * * example 6 * * claim - * [I] 1,3-17; | [XI]EP0529123 (SEKISUI CHEMICAL CO LTD [JP]) [X] 1,3,5,6,8-11,14,15 * page 2, line 54 - line 58 * * page 3, line 26 - line 36 * * examples 4-7; tables 1,2 * * claim - * [I] 1,3-17; | [A]US2005175678 (BREITENBACH ARMIN [DE]) [A] 1,3-17 * paragraph [0001] - paragraph [0002] * * paragraph [0014] * * paragraph [0022] - paragraph [0033] * * example - * * claim - *; | [A] - INOUE ET AL, "Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20051128), vol. 108, no. 2-3, ISSN 0168-3659, pages 306 - 318, XP005163073 [A] 1,3-17 * abstract * * paragraph [02.1] * * paragraph [02.6] * * paragraph [03.2] - paragraph [03.4]; table 1 * * paragraph [03.7]; figure 7 * * paragraph [0004] * DOI: http://dx.doi.org/10.1016/j.jconrel.2005.08.008 | by applicant | US5164190 | US4409206 | US2005064022 | US2005175678 | US6902741 | US4490322 | US4797284 | US4880633 | US5352457 | US5869089 | US5906830 | US6153216 | US6156335 | US6623763 | US4490332 | US6465005 | US5676968 | US6440454 | US6537576 | US5229130 |